Contact
Please use this form to send email to PR contact of this press release:
Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation
TO:
Please use this form to send email to PR contact of this press release:
Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation
TO: